Stefan C Meuer

Title: Innovations of Stefan C. Meuer in Monoclonal Antibodies

Introduction

Stefan C. Meuer is a notable inventor based in Alzey, Germany. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work focuses on creating targeted therapies for autoimmune diseases, showcasing the potential of innovative medical treatments.

Latest Patents

Stefan C. Meuer holds a patent for "Monoclonal antibodies that recognize human T cells." This invention involves a monoclonal antibody that specifically binds to the surface recognition structure of a predetermined mature human T cell clone. The antibody is designed to inhibit the ability of the T cell clone to act as a causative agent in specific autoimmune diseases. This patent represents a significant advancement in targeted immunotherapy.

Career Highlights

Stefan C. Meuer is associated with the Dana-Farber Cancer Institute Inc., where he collaborates with leading researchers in the field. His work has contributed to a deeper understanding of T cell behavior and its implications in autoimmune conditions. With a focus on innovative solutions, he continues to push the boundaries of medical research.

Collaborations

Some of his notable coworkers include Ellis L. Reinherz and Stuart F. Schlossman. Their collaborative efforts have further enhanced the research and development of monoclonal antibodies, leading to breakthroughs in treatment options for patients.

Conclusion

Stefan C. Meuer's contributions to the field of immunology through his patent on monoclonal antibodies highlight the importance of innovation in medical science. His work not only advances our understanding of autoimmune diseases but also paves the way for future therapeutic developments.